From the Lab
Reprogram Skin Cells to Behave Like Embryonic Stem Cells
In their paper, published in the latest early online edition
of Proceedings of the National Academy of the Sciences,
Katherine Prath and William Lowery confirm the work of researchers Shinya Yamanaka at Kyoto
University and James Thomson at the University of
Wisconsin, who first
reported such advance in November 2007 ... read
Mitochondrial DNA Mutations
Can Cause Degenerative Heart and Muscle Disease
A single change in the DNA of mitochondria –
the cellular power plants that generate energy in all human cells
– has been found to cause degenerative heart and muscle disease,
according to University of California, Irvine research team led by
by Douglas Wallace
(photo right), director of the Center for
Molecular and Mitochondrial Medicine and Genetics at UC Irvine .. read
Artificial Retinal Implant Project Grows
University of Southern California and Second Sight Medical Products (Sylmar), the developer of retinal prostheses for treating blindness, are
expanding the clinical trial of an advanced retinal prosthesis into
CEO: Bone Drug Started With a ‘Really Big Mouse’
Amgen CEO Kevin Sharer touted the company's chances in developing denosumab (D-mab) into a badly needed blockbuster. The discovery program began in an Amgen lab when researchers observed that one of the knockout mice it had developed during gene disabling research work had grown huge.
Southland Firms Fight Over Percutaneous Heart Valve Technology
The Irvine-based Edwards Lifesciences, which
dominates the market for replacement heart valves, filed a patent-infringement
suit against CoreValve (also in Irvine) on Tuesday in Delaware. At issue is
technology that both companies have developed for implanting
replacement heart valves through catheters, without major
refutes alleged patent infringement action by Edwards.
Edwards Lifesciences Realigns Business
Company announced on
February 18 that it plans to realign its company into a business
unit organizational structure and said corporate officers -- Anita
Bessler, Stuart Foster, and Alex Martin -- will be leaving the
company in the middle of 2008 ... read
Therapeutics Completes Acquisition of Molecular Antibody
The technology acquired by the Los Angeles-based company consists
of (i) a platform technology for the potentially rapid
discovery of monoclonal antibodies to detect and treat cancer and
other chronic diseases and (ii) certain monoclonal antibody
candidates for the potential detection and treatment of multiple
myeloma, small cell lung, pancreatic and ovarian cancers ...
read press release
Mentor Announces an Alliance with Le Mystere and
Launches an Online Resource on Breast Augmentation
and Cosmetic Procedures
The Santa Barbara-based
breast implant maker unveiled a partnership with Le Mystčre
on a variety of marketing and educational initiatives targeting
women who are considering breast surgery. This move follows
Mentor's launch of an online
educational resource for women considering breast augmentation
and other cosmetic procedures at www.LoveYourLook.com.
7:00 – 9:30 am
UCI University Club (Irvine, CA)
Can Less be More?
The Advantages and Challenges of Operating
These days, an increasing number of
biotech and device companies -- often with prodding from the venture
capitalists who back them -- are operating virtually on the premise that
less can be more. Join us for a discussion by local device and biotech
firms of the advantages and challenges of the virtual
mode of doing business.
- Frank Ahmann, Chief Operating Officer, Symphony Medical (Laguna
- Alan H.
Auerbach, Chief Executive Officer,
Cougar Biotechnology (West Los Angeles)
Gallagher, Managing Partner, LS
- D. Verne Sharma, Director, Visitome (Irvine)
- Susan Wong, Head of Life Science Practice, LS Technologies
February 29, 2008
8:00 am - 6:00 pm
Wilshire Grand Hotel, Los Angeles
Here to RSVP
SoCalBio Human Resources Conference
SoCalBio has assembled an impressive roster of over 20 outstanding keynote speakers and panelists who will tackle human resources issues of relevance to small and mid-size biotech and device companies, from the role of HR in creating a competitive edge, new educational and workforce training initiatives in Southern California, to practical tips on avoiding the top reasons companies get sued because of HR matters.
Business Strategy for Senior HR Leaders
March 3-6, 2008
Rady School of Management, UC San Diego
This is the last U.S. offering by world renowned expert Dr. Phil Parker. Become a major player at both the strategic and functional level in your company by aligning HR tactics with your CEO's corporate vision.
HRCI Approved: 27.75 recertification hours toward PHR, SPHR and GPHR.
SoCalBio members receive $300 discount, (promotion code:
socalbio). Additional information and online registration:
|The Southern California Biomedical Council (SCBC
or SoCalBio) is a nonprofit, member-supported trade association that promotes
biomedical and life science research, development, manufacturing and overall
economic development in Los Angeles, Orange County and adjacent communities.
The organization’s programs assist local firms in
accessing capital, potential partners and business support services. They also
promote technology transfer and workforce training and educate the public and
policy makers about the economic and social benefits of the life-science